The effects of aging and chronic fluoxetine treatment on circadian rhythms and suprachiasmatic nucleus expression of neuropeptide genes and 5‐HT1Breceptors

Jun 8, 2010The European journal of neuroscience

How Aging and Long-Term Fluoxetine Use Affect Daily Body Clocks and Brain Signals Controlling Them

AI simplified

Abstract

Aging decreases SCN expression of mRNA for gastrin-releasing peptide, which modulates photic phase resetting.

  • Age-related changes in circadian rhythms may be linked to alterations in the central pacemaker in the suprachiasmatic nucleus (SCN).
  • Aging decreases the expression of mRNA for vasoactive intestinal peptide (VIP) and increases expression of serotonin transporters and 5-HT(1B) receptors.
  • Chronic administration of the serotonin-selective reuptake inhibitor fluoxetine does not affect SCN VIP mRNA expression in either age group.
  • Fluoxetine treatment prevents the age-related increase in SCN 5-HT(1B) receptors at ZT6 and decreases them in both age groups at ZT13.
  • Aging and chronic fluoxetine treatment result in decreased total daily wheel running without changing the phase of the circadian wheel running rhythm.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free